Developing an implantable system for automatic insulin delivery
The Optimal Pathway to Implanted Autonomous Insulin Delivery
This study is testing a new insulin delivery system that automatically adjusts insulin levels for people with diabetes, making it easier and faster to manage their blood sugar without needing constant help.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Stanford University NIH-funded |
| Lab location | 1 site (Stanford, United States) |
| Project ID | NIH-10833609 on NIH RePORTER |
What this research studies
This research focuses on creating a new type of insulin delivery system that can automatically adjust insulin levels in patients with diabetes. The approach involves using intraperitoneal delivery, which allows for faster insulin action compared to traditional methods. The research aims to enhance user satisfaction and glycemic control while minimizing the need for patient intervention. By understanding how to optimize this delivery method, the goal is to develop a fully autonomous implantable insulin delivery system.
Who could benefit from this research
Good fit: Ideal candidates for this research are adults with type 1 diabetes who are seeking improved methods of insulin management.
Not a fit: Patients who do not have diabetes or those who are not suitable candidates for insulin therapy may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a more effective and user-friendly insulin delivery system for individuals with diabetes.
How similar studies have performed: Previous studies on closed-loop insulin delivery systems have shown promise, but this approach focusing on intraperitoneal delivery is relatively novel.
Where this research is happening
Stanford, United States
- Stanford University — Stanford, United States (Active)
Researchers
- Principal investigator: Lal, Rayhan — Stanford University
- Study coordinator: Lal, Rayhan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.